Category Archives: AMD


RCA Announces First Virtual Town Hall

Retinal Consultants of Arizona is proud to announce its first Virtual Town Hall Patient Education Program. This program is designed to inform and educate community members about conditions of the retina and vitreous including Age-Related Macular Degeneration and Diabetic Eye Diseases. The purpose is to increase early detection and intervention to common retina conditions, which… Read More »



Anti-PDGF, anti-VEGF combination may be game changer in wet AMD treatment

“Anti-VEGF monotherapy will go down in medical history as a treatment model that was both insurmountable and unsustainable.” “It was insurmountable because of the historic gains that were seen in a disease, neovascular macular degeneration, that had miserable treatment results earlier. We went from essentially not being able to treat our patients at all and… Read More »


Anti-PDGF Combination Agent More Effective Than Ranibizumab Monotherapy for Wet AMD

“The anti-platelet derived growth factor (PDGF) combination agent Fovista (Ophthotech Corp.) showed statistically significant superior efficacy over ranibizumab (Lucentis, Genentech) monotherapy for the treatment of wet AMD, according to the results of a phase 2b study, which were recently reported in an Ophthotech release…” Retinal Consultants of AZ is committed to clinical research and the… Read More »